Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues
Investment banking	$ 9,348	$ 7,738	$ 6,218
Investment management	11,749	10,596	9,532
Commissions and fees	4,042	4,086	3,789
Market making	17,993	18,390	18,238
Other principal transactions	1,592	4,646	2,126
Total non-interest revenues	44,724	45,456	39,903
Interest income	80,373	81,397	68,515
Interest expense	66,814	73,341	62,164
Net interest income	13,559	8,056	6,351
Total net revenues	58,283	53,512	46,254
Provision for credit losses	(1,113)	1,348	1,028
Operating expenses
Compensation and benefits	18,906	16,706	15,499
Transaction based	7,997	6,724	5,698
Market development	710	646	629
Communications and technology	2,170	1,991	1,919
Depreciation and amortization	2,182	2,392	4,856
Occupancy	958	973	1,053
Professional fees	1,770	1,652	1,623
Other expenses	2,851	2,683	3,210
Total operating expenses	37,544	33,767	34,487
Pre-tax earnings	21,852	18,397	10,739
Provision for taxes	4,676	4,121	2,223
Net earnings	17,176	14,276	8,516
Preferred stock dividends	876	751	609
Net earnings applicable to common shareholders	$ 16,300	$ 13,525	$ 7,907
Earnings per common share
Basic (in dollars per share)	$ 51.95	$ 41.07	$ 23.05
Diluted (in dollars per share)	$ 51.32	$ 40.54	$ 22.87
Average common shares
Basic (in shares)	312.7	328.1	340.8
Diluted (in shares)	317.6	333.6	345.8

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net earnings	$ 17,176	$ 14,276	$ 8,516
Adjustments to reconcile net earnings to net cash used for operating activities:
Depreciation and amortization	2,182	2,392	4,856
Deferred income taxes	204	(800)	(1,360)
Share-based compensation	3,445	2,663	2,085
Provision for credit losses	(1,113)	1,348	1,028
Changes in operating assets and liabilities:
Customer and other receivables and payables, net	(43,206)	(8,367)	(28,219)
Collateralized transactions (excluding other secured financings), net	(12,891)	68,582	160,227
Trading assets	(69,866)	(86,991)	(163,807)
Trading liabilities	57,560	(212)	5,751
Loans held for sale, net	(504)	537	1,635
Other, net	1,859	(6,640)	(3,299)
Net cash used for operating activities	(45,154)	(13,212)	(12,587)
Cash flows from investing activities
Purchase of property, leasehold improvements and equipment	(2,064)	(2,091)	(2,316)
Proceeds from sales of property, leasehold improvements and equipment	803	1,613	3,278
Net cash received from business dispositions	1,536	3,622	487
Available-for-sale securities:
Purchases	(77,429)	(60,852)	(9,185)
Proceeds from sales	61,325	19,005	3,161
Proceeds from paydowns and maturities	43	12,809	8,130
Held-to-maturity securities:
Purchases	(11,279)	(23,018)	(26,238)
Proceeds from paydowns and maturities	21,687	15,549	8,604
Other investments:
Purchases	(9,392)	(8,226)	(4,833)
Proceeds from sales, paydowns and maturities	9,892	9,010	6,953
Loans (excluding loans held for sale), net	(39,349)	(17,045)	(5,353)
Net cash used for investing activities	(44,227)	(49,624)	(17,312)
Cash flows from financing activities
Unsecured short-term borrowings, net	2,988	934	2,050
Other secured financings (short-term), net	(3,877)	13,707	673
Proceeds from issuance of other secured financings (long-term)	6,510	5,243	3,047
Repayment of other secured financings (long-term), including the current portion	(3,331)	(2,036)	(3,570)
Proceeds from issuance of unsecured long-term borrowings	88,196	67,252	47,153
Repayment of unsecured long-term borrowings, including the current portion	(71,502)	(74,519)	(54,066)
Derivative contracts with a financing element, net	2,313	2,390	3,280
Deposits, net	62,783	5,894	39,723
Preferred stock redemption	0	(2,200)	(1,000)
Common stock repurchased	(12,360)	(8,000)	(5,796)
Settlement of share-based awards in satisfaction of withholding tax requirements	(2,156)	(1,331)	(1,345)
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards	(5,277)	(4,497)	(4,189)
Proceeds from issuance of preferred stock, net of issuance costs	1,895	4,239	1,496
Other financing, net	(82)	247	344
Net cash provided by financing activities	66,100	7,323	27,800
Effect of exchange rate changes on cash and cash equivalents	5,448	(3,972)	1,851
Net decrease in cash and cash equivalents	(17,833)	(59,485)	(248)
Cash and cash equivalents, beginning balance	182,092	241,577	241,825
Cash and cash equivalents, ending balance	164,259	182,092	241,577
Supplemental disclosures:
Cash payments for interest, net of capitalized interest	65,494	72,623	60,026
Cash payments for income taxes, net	$ 3,990	$ 3,673	$ 2,389

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	$ 164,259	$ 182,092
Collateralized agreements
Securities purchased under agreements to resell (includes $126,007 and $179,793 at fair value)	126,007	180,062
Securities borrowed (includes $51,581 and $46,902 at fair value)	208,208	194,645
Customer and other receivables (includes $315 and $23 at fair value)	185,842	133,717
Trading assets (at fair value and includes $158,641 and $148,417 pledged as collateral)	656,796	570,555
Investments:
Available-for-sale securities (at fair value; amortized cost of $99,116 and $80,777)	99,244	79,458
Held-to-maturity securities	69,193	78,713
Other investments (includes $24,938 and $25,284 at fair value)	25,825	26,343
Loans (net of allowance of $2,148 and $4,666, and includes $4,905 and $5,460 at fair value)	237,734	196,200
Other assets (includes $180 and $194 at fair value)	36,212	34,187
Total assets	1,809,320	1,675,972
Liabilities and shareholders’ equity
Deposits (includes $76,569 and $44,855 at fair value)	501,422	433,013
Collateralized financings
Securities sold under agreements to repurchase (at fair value)	223,384	274,380
Securities loaned (includes $11,995 and $10,246 at fair value)	53,644	56,060
Other secured financings (includes $27,833 and $27,985 at fair value)	28,021	28,150
Customer and other payables	231,865	223,255
Trading liabilities (at fair value)	262,552	202,555
Unsecured short-term borrowings	70,459	69,709
Unsecured long-term borrowings (includes $112,683 and $89,189 at fair value)	285,500	242,634
Other liabilities (includes $111 and $84 at fair value)	27,501	24,220
Total liabilities	1,684,348	1,553,976
Commitments, contingencies and guarantees
Shareholders’ equity
Preferred stock; aggregate liquidation preference of $15,153 and $13,253	15,153	13,253
Common stock; 931,995,446 and 927,499,667 shares issued, and 296,476,742 and 310,653,708 shares outstanding	9	9
Share-based awards	5,795	5,148
Nonvoting common stock; no shares issued and outstanding	0	0
Additional paid-in capital	61,906	61,376
Retained earnings	165,288	153,412
Accumulated other comprehensive loss	(2,260)	(2,702)
Stock held in treasury, at cost; 635,518,706 and 616,845,961 shares	(120,919)	(108,500)
Total shareholders’ equity	124,972	121,996
Total liabilities and shareholders’ equity	$ 1,809,320	$ 1,675,972